BAK
BAK
Braskem S.A.Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q4-2025 | $14.71B ▼ | $1.58B ▲ | $-10.44B ▼ | -70.97% ▼ | $-26.18 ▼ | $-1B ▲ |
| Q3-2025 | $17.3B ▼ | $1.36B ▲ | $-26M ▲ | -0.15% ▲ | $-0.07 ▲ | $-1.02B ▼ |
| Q2-2025 | $17.86B ▼ | $1.32B ▲ | $-267M ▼ | -1.5% ▼ | $-0.66 ▼ | $2.36B ▼ |
| Q1-2025 | $19.46B ▲ | $1.21B ▼ | $698M ▲ | 3.59% ▲ | $1.76 ▲ | $3.26B ▲ |
| Q4-2024 | $19.15B | $1.45B | $-5.65B | -29.48% | $-14.18 | $-1.06B |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q4-2025 | $11.83B ▲ | $81.84B ▼ | $98.33B ▲ | $-16.14B ▼ |
| Q3-2025 | $7.41B ▼ | $87.38B ▼ | $90.56B ▼ | $-3.53B ▲ |
| Q2-2025 | $10.3B ▼ | $91.3B ▼ | $94.56B ▼ | $-3.81B ▲ |
| Q1-2025 | $13.03B ▼ | $95.42B ▼ | $99.22B ▼ | $-4.24B ▲ |
| Q4-2024 | $16.77B | $101.58B | $105.85B | $-4.78B |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q4-2025 | $-10.44B ▼ | $-901.33M ▼ | $-658.25M ▲ | $5.04B ▲ | $3.64B ▲ | $-1.48B ▲ |
| Q3-2025 | $-26M ▲ | $-683M ▼ | $-1.06B ▼ | $-732M ▲ | $-2.52B ▼ | $-1.95B ▼ |
| Q2-2025 | $-267M ▼ | $-285M ▲ | $-696M ▼ | $-1.04B ▼ | $-2.13B ▲ | $-933M ▲ |
| Q1-2025 | $698M ▲ | $-2.33B ▼ | $-576M ▲ | $-191M ▼ | $-3.67B ▼ | $-2.98B ▼ |
| Q4-2024 | $-8.33B | $817M | $-1.02B | $2.39B | $3.07B | $-215M |
Q4 2025 Earnings Call Summary
Read Call Summary5-Year Trend Analysis
A comprehensive look at Braskem S.A.'s financial evolution and strategic trajectory over the past five years.
Braskem’s key strengths include its large industrial scale, strong presence in the Americas, and deep technical expertise in polymers. Its early and sustained investment in bio‑based and recycled materials gives it differentiated products and strong alignment with global sustainability trends. The company maintains a sizable asset base, ongoing R&D programs, and the operational know‑how to produce at scale across multiple product families and regions.
Major risks center on financial health and industry structure. The company is currently loss‑making, with thin operating margins, negative net income, and substantial cash burn. Its balance sheet shows very high leverage and negative equity, heightening solvency and refinancing risk if conditions worsen. It is also exposed to cyclical demand, volatile feedstock costs, environmental regulation, and competitive pressure from large global petrochemical players, all of which can compress margins further.
The outlook hinges on Braskem’s ability to execute a turnaround while advancing its sustainability‑focused strategy. If industry conditions normalize and the company can improve efficiency, reduce debt over time, and scale higher‑margin, lower‑carbon products, its innovation efforts and market position could support a more stable future. Conversely, if weak margins and cash burn persist, the combination of high leverage and capital intensity could force difficult financial or strategic decisions. Overall, the story is one of strong industrial and technological assets weighed down by a currently stressed financial position.
About Braskem S.A.
https://www.braskem.com.brBraskem S.A., together with its subsidiaries, produces and sells thermoplastic resins. The company operates through three segments: Brazil, United States and Europe, and Mexico.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q4-2025 | $14.71B ▼ | $1.58B ▲ | $-10.44B ▼ | -70.97% ▼ | $-26.18 ▼ | $-1B ▲ |
| Q3-2025 | $17.3B ▼ | $1.36B ▲ | $-26M ▲ | -0.15% ▲ | $-0.07 ▲ | $-1.02B ▼ |
| Q2-2025 | $17.86B ▼ | $1.32B ▲ | $-267M ▼ | -1.5% ▼ | $-0.66 ▼ | $2.36B ▼ |
| Q1-2025 | $19.46B ▲ | $1.21B ▼ | $698M ▲ | 3.59% ▲ | $1.76 ▲ | $3.26B ▲ |
| Q4-2024 | $19.15B | $1.45B | $-5.65B | -29.48% | $-14.18 | $-1.06B |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q4-2025 | $11.83B ▲ | $81.84B ▼ | $98.33B ▲ | $-16.14B ▼ |
| Q3-2025 | $7.41B ▼ | $87.38B ▼ | $90.56B ▼ | $-3.53B ▲ |
| Q2-2025 | $10.3B ▼ | $91.3B ▼ | $94.56B ▼ | $-3.81B ▲ |
| Q1-2025 | $13.03B ▼ | $95.42B ▼ | $99.22B ▼ | $-4.24B ▲ |
| Q4-2024 | $16.77B | $101.58B | $105.85B | $-4.78B |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q4-2025 | $-10.44B ▼ | $-901.33M ▼ | $-658.25M ▲ | $5.04B ▲ | $3.64B ▲ | $-1.48B ▲ |
| Q3-2025 | $-26M ▲ | $-683M ▼ | $-1.06B ▼ | $-732M ▲ | $-2.52B ▼ | $-1.95B ▼ |
| Q2-2025 | $-267M ▼ | $-285M ▲ | $-696M ▼ | $-1.04B ▼ | $-2.13B ▲ | $-933M ▲ |
| Q1-2025 | $698M ▲ | $-2.33B ▼ | $-576M ▲ | $-191M ▼ | $-3.67B ▼ | $-2.98B ▼ |
| Q4-2024 | $-8.33B | $817M | $-1.02B | $2.39B | $3.07B | $-215M |
Q4 2025 Earnings Call Summary
Read Call Summary5-Year Trend Analysis
A comprehensive look at Braskem S.A.'s financial evolution and strategic trajectory over the past five years.
Braskem’s key strengths include its large industrial scale, strong presence in the Americas, and deep technical expertise in polymers. Its early and sustained investment in bio‑based and recycled materials gives it differentiated products and strong alignment with global sustainability trends. The company maintains a sizable asset base, ongoing R&D programs, and the operational know‑how to produce at scale across multiple product families and regions.
Major risks center on financial health and industry structure. The company is currently loss‑making, with thin operating margins, negative net income, and substantial cash burn. Its balance sheet shows very high leverage and negative equity, heightening solvency and refinancing risk if conditions worsen. It is also exposed to cyclical demand, volatile feedstock costs, environmental regulation, and competitive pressure from large global petrochemical players, all of which can compress margins further.
The outlook hinges on Braskem’s ability to execute a turnaround while advancing its sustainability‑focused strategy. If industry conditions normalize and the company can improve efficiency, reduce debt over time, and scale higher‑margin, lower‑carbon products, its innovation efforts and market position could support a more stable future. Conversely, if weak margins and cash burn persist, the combination of high leverage and capital intensity could force difficult financial or strategic decisions. Overall, the story is one of strong industrial and technological assets weighed down by a currently stressed financial position.

CEO
Roberto Prisco Paraíso Ramos
Compensation Summary
(Year )
Upcoming Earnings
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2005-05-16 | Forward | 2:1 |
ETFs Holding This Stock
Summary
Showing Top 3 of 9
Ratings Snapshot
Rating : B-
Most Recent Analyst Grades
Grade Summary
Showing Top 2 of 2
Price Target
Institutional Ownership
UBS GROUP AG
Shares:783.45K
Value:$2.93M
VANGUARD GROUP INC
Shares:560.47K
Value:$2.1M
RUSSELL FRANK CO/
Shares:379.3K
Value:$1.42M
Summary
Showing Top 3 of 84

